Search

David Ow Phones & Addresses

  • San Francisco, CA
  • 127 Glenwood, Hercules, CA 94547
  • 127 Brenner, Hercules, CA 94547
  • Rodeo, CA
  • 555 Pierce St APT 1310, Albany, CA 94706 (510) 828-3549

Work

Company: Ow consulting Address: 127 Brenner, Rodeo, CA 94547 Phones: (510) 724-4976 Position: Partner Industries: Business Consulting Services

Business Records

Name / Title
Company / Classification
Phones & Addresses
David Ow
Partner
OW Consulting
Business Consulting Services
127 Brenner, Rodeo, CA 94547
David Ow
Partner
Ow Consulting
Business Consulting Services · Other Scientific and Technical Consulting Services
127 Brenner, Rodeo, CA 94547
(510) 724-4976
David Ow
Partner
OW Consulting
Business Consulting Services
127 Brenner, Rodeo, CA 94547

Publications

Us Patents

Dna Recombination In Eukaryotic Cells By The Bacteriophage Phic31 Recombination System

View page
US Patent:
6746870, Jun 8, 2004
Filed:
Jul 21, 2000
Appl. No.:
09/620800
Inventors:
David W. Ow - Hercules CA
Richard Calendar - Berkeley CA
Lynn Thomason - Albany CA
Assignee:
The Regents of the University of California - Oakland CA
The United States of America as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N 1574
US Classification:
435477, 435471, 4353201, 43525235
Abstract:
This invention provides methods for obtaining specific and stable integration of nucleic acids into eukaryotic cells. The invention makes use of site-specific recombination systems that use prokaryotic recombinase polypeptides, such as the C31 integrase, that can mediate recombination between the recombination sites, but not between hybrid recombination sites that are formed upon the recombination. Thus, the recombination is irreversible in the absence of additional factors. Eukaryotic cells that contain the recombinase polypeptides, or genes that encode the recombinases, are also provided.

Methods For The Replacement, Translocation And Stacking Of Dna In Eukaryotic Genomes

View page
US Patent:
6936747, Aug 30, 2005
Filed:
Jul 23, 2001
Appl. No.:
09/911088
Inventors:
David W. Ow - Hercules CA, US
Assignee:
The United States of America as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N015/82
C12N015/87
C12N015/74
C12N005/14
A01H005/00
US Classification:
800294, 800288, 800306, 800278, 536 231, 4353201, 435419
Abstract:
The present invention includes compositions and methods for site-specific polynucleotide replacement in eukaryotic cells. These methods include single polynucleotide replacement as well as gene stacking methods. Preferred eukaryotic cells for use in the present invention are plant cells and mammalian cells.

Methods For The Replacement, Translocation And Stacking Of Dna In Eukaryotic Genomes

View page
US Patent:
7972857, Jul 5, 2011
Filed:
Aug 6, 2004
Appl. No.:
10/913085
Inventors:
David W. Ow - Hercules CA, US
Assignee:
The United States of America as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N 15/74
C12N 15/00
US Classification:
435477, 4353201
Abstract:
The present invention includes compositions and methods for site-specific polynucleotide replacement in eukaryotic cells. These methods include single polynucleotide replacement as well as gene stacking methods. Preferred eukaryotic cells for use in the present invention are plant cells and mammalian cells.

Dna Recombination In Eukaryotic Cells By The Bacteriophage Phic31 Recombination System

View page
US Patent:
8129598, Mar 6, 2012
Filed:
Nov 24, 2003
Appl. No.:
10/721980
Inventors:
David W. Ow - Hercules CA, US
Richard Calendar - Berkeley CA, US
Lynn Thomason - Albany CA, US
Assignee:
The Regents of the University of California - Oakland CA
The United States of America as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N 5/04
US Classification:
8003173, 4352542, 435462, 435468, 435471, 435419, 4352351, 435475, 435410
Abstract:
This invention provides methods for obtaining specific and stable integration of nucleic acids into eukaryotic cells. The invention makes use of site-specific recombination systems that use prokaryotic recombinase polypeptides, such as the ΦC31 integrase, that can mediate recombination between the recombination sites, but not between hybrid recombination sites that are formed upon the recombination. Thus, the recombination is irreversible in the absence of additional factors. Eukaryotic cells that contain the recombinase polypeptides, or genes that encode the recombinases, are also provided.

Site-Specific Recombination Systems For Use In Eukaryotic Cells

View page
US Patent:
20060046294, Mar 2, 2006
Filed:
Aug 22, 2005
Appl. No.:
11/209388
Inventors:
David Ow - Hercules CA, US
James Thomson - Albany CA, US
Assignee:
The United States of America, as Represented by The Secretary of Agriculture - Washington DC
International Classification:
C12N 15/86
C12N 15/82
US Classification:
435456000, 435468000
Abstract:
Prokaryotic recombination systems have been adapted to function in eukaryotes in order to achieve one or more of the following: DNA site specific excision, translocation, integration and inversion. These recombination systems are identified as seven members of the small serine resolvase subfamily: CinH, ParA, Tn1721, Tn5053, Tn21, Tn402, and Tn501 and three members of the large serine resolvase subfamily: Bxb1, U153, and TP901-1. These recombination systems represent new tools for the genetic manipulation of eukaryotic genomes.

Site-Specific Recombination Systems For Use In Eukaryotic Cells

View page
US Patent:
20100068815, Mar 18, 2010
Filed:
Jun 30, 2009
Appl. No.:
12/494772
Inventors:
David W. Ow - Hercules CA, US
James G. Thomson - Albany CA, US
Assignee:
The United States of America, as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N 15/87
US Classification:
435462, 435468
Abstract:
Prokaryotic recombination systems have been adapted to function in eukaryotes in order to achieve one or more of the following: DNA site specific excision, translocation, integration and inversion. These recombination systems are identified as seven members of the small serine resolvase subfamily: CinH, ParA, Tn1721, Tn5053, Tn21, Tn402, and Tn501 and three members of the large serine resolvase subfamily: Bxb1, U153, and TP901-1. These recombination systems represent new tools for the genetic manipulation of eukaryotic genomes.

Site-Specific Recombination Systems For Use In Eukaryotic Cells

View page
US Patent:
20110136237, Jun 9, 2011
Filed:
Aug 18, 2010
Appl. No.:
12/859229
Inventors:
David W. Ow - Hercules CA, US
James G Thomson - Albany CA, US
Assignee:
The United States of America, as represented by the Secretary of Agriculture - Washington DC
International Classification:
C12N 15/87
US Classification:
435462, 435468, 435440, 435471
Abstract:
Prokaryotic recombination systems have been adapted to function in eukaryotes in order to achieve one or more of the following: DNA site specific excision, translocation, integration and inversion. These recombination systems are identified as seven members of the small serine resolvase subfamily: CinH, ParA, Tn1721, Tn5053, Tn21, Tn402, and Tn501 and three members of the large serine resolvase subfamily: Bxb1, U153, and TP901-1. These recombination systems represent new tools for the genetic manipulation of eukaryotic genomes.

Dna Sequences Encoding Coleoptera Luciferase Activity

View page
US Patent:
56747136, Oct 7, 1997
Filed:
Jun 2, 1995
Appl. No.:
8/460214
Inventors:
Marlene DeLuca McElroy - late of La Jolla CA
Donald Raymond Helinski - La Jolla CA
Keith Vernon Wood - San Diego CA
Jeffrey Roux De Wet - Menlo Park CA
David Wing Ow - San Francisco CA
Stephen Herbert Howell - Del Mar CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C12N 121
C12N 510
C12N 1553
C12N 902
US Classification:
435 697
Abstract:
DNA compositions and methods of constructing and using the same consisting of DNA sequences encoding luciferase activity, or DNA sequences encoding hybrid molecules exhibiting luciferase activity and a second biological activity that are useful in performing biological assays.
David Wind Ow from San Francisco, CA, age ~69 Get Report